Scott J. Dylla
Director, Proteostasis Therapeutics (United States).
Companies
- Proteostasis Therapeutics (United States)Board member Jul 5, 2023 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Proteostasis Therapeutics (United States)0 shares2Jun 30, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 30, 2025Returned to company 17,794 shares of Proteostasis Therapeutics (United States)2
- Jun 25, 2025Granted 6,000 shares of Proteostasis Therapeutics (United States)3
- Jun 23, 2025Shares withheld for tax 4,706 shares at $0.26 of Proteostasis Therapeutics (United States)3
- Jun 23, 2025Exercised options 12,500 shares at $0.61 of Proteostasis Therapeutics (United States)3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jun 25, 2025